Zbynek Bortlicek

Clinical and laboratory prognostic factors in patients with metastatic renal cell carcinoma treated with sunitinib and sorafenib after progression on cytokines

2014 | 2. lékařská fakulta, 1. lékařská fakulta

Publikace